Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-13-046524
Filing Date
2013-12-17
Accepted
2013-12-17 16:14:22
Documents
1
Period of Report
2013-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 5852
  Complete submission text file 0001140361-13-046524.txt   7547
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Issuer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 WISCONSIN CIR SUITE 660 CHEVY CHASE MD 20815
Business Address 2 WISCONSIN CIR SUITE 660 CHEVY CHASE MD 20815 301-656-8500
Roumell Asset Management, LLC (Reporting) CIK: 0001331693 (see all company filings)

State of Incorp.: MD | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36066 | Film No.: 131281997